Scotiabank Reaffirms Their Buy Rating on Healthcare Realty Trust (HR)
In a report released today, Nicholas Yulico from Scotiabank maintained a Buy rating on Healthcare Realty Trust, with a price target of $20.00. The company’s shares opened today at $17.82.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Yulico covers the Real Estate sector, focusing on stocks such as Healthcare Realty Trust, BXP, and Equity Residential. According to TipRanks, Yulico has an average return of 1.7% and a 46.26% success rate on recommended stocks.
Currently, the analyst consensus on Healthcare Realty Trust is a Hold with an average price target of $19.13.
HR market cap is currently $6.24B and has a P/E ratio of -15.39.
Based on the recent corporate insider activity of 42 insiders, corporate insider sentiment is neutral on the stock.
Read More on HR:
Disclaimer & DisclosureReport an Issue
- Cautious Optimism: Hold Rating Maintained for Healthcare Realty Trust Amid Strategic Progress and Modest Financial Guidance
- Healthcare Realty Trust Reports Q3 2025 Financial Results
- Healthcare Realty Trust reports Q3 normalized FFO 41c, consensus 40c
- Healthcare Realty Trust narrows FY25 FFO view to $1.59-$1.60 from $1.57-$1.61
- Is HR a Buy, Before Earnings?
